-
1
-
2
Esomeprazole and aspirin in Barrett's oesophagus (AspECT): a randomised factorial trial
Published 2018“…Background: Oesophageal adenocarcinoma (OA) is the sixth commonest cause of cancer death worldwide and Barrett’s oesophagus (BO) is the most significant risk factor. …”
Journal article -
3
Esomeprazole and aspirin in Barrett's oesophagus (AspECT): a randomised factorial trial
Published 2018“… <h4>Background</h4> <p>Oesophageal adenocarcinoma is the sixth most common cause of cancer death worldwide and Barrett’s oesophagus is the biggest risk factor. …”
Journal article -
4
Chemoprevention of esophageal cancer with esomeprazole and aspirin therapy: efficacy and safety in the phase III randomized factorial AspECT Trial
Published 2018“…Esophageal adenocarcinoma (EA) is the sixth most common cause of global cancer death. We rely on endoscopy screening to identify and monitor patients with Barrett’s esophagus (BE) and find neoplastic lesions early enough to manage their EA. …”
Conference item